Cases & Deals

  • Home
  • Practices
  • TissueTech issues Common Stock in private placement to certain accredited investors

Share

TissueTech issues Common Stock in private placement to certain accredited investors

September 2012

Client(s) TissueTech, Inc.

Jones Day advised TissueTech, Inc., a Miami-based bio-tech company and industry leader in amniotic membrane tissue products, in connection with its issuance of Common Stock in a private placement to certain accredited investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.